Medical Health & Life Science Research News

Learn details of the proteomics market forecast to 2023

Proteomes are an entire set of proteins which is expressed in genomes, and proteomics refers to the large-scale study of these proteomes, that include study of the functions and structure of proteins that can be used in diagnosis and treatment of various diseases, and in the process of drug discovery.

Proteomics is used to analyze the interaction of proteins with each other, action of proteins in metabolic pathways, rate of the production of proteins, and the modification process of the proteins. Additionally, it is extensively applied in personalized medicine development, and marker identification for disease diagnosis.

Global proteomics market is expected to grow significantly in the forecasted period due to the rising demand for personalized medicine and increasing investment in research and development activities, globally.

Explore Report at: www.psmarketresearch.com/market-analysis/proteomics-market

Based on the instrumentation technology, the global proteomics market is segmented into protein microarrays, spectroscopy, x-ray crystallography, chromatography, electrophoresis, surface plasmon resonance (SPR) systems, and protein fractionation systems. Protein microarray held the largest segment of the global market in 2016, mainly due to its ability to produce large number of results from a small sample.

Moreover, it provides label-free detection, full imprint of proteins, and direct and absolute quantification.

Request to Sample: https://www.psmarketresearch.com/market-analysis/proteomics-market/report-sample

Some of the key players in the global proteomics market are Agilent Technologies Inc., Bruker Corporation, GE Healthcare, Merck KGaA, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Waters Corporation, Danaher Corporation, Luminex Corporation, and PerkinElmer Inc.

Report Enquiry at:  www.psmarketresearch.com/send-enquiry?enquiry-url=proteomics-market

With respect to strategic developments, various new product launches and strategic alliances have been taking place in the patient positioning equipment market.

In June 2017, Waters Corporation introduced the latest version of Progenesis QI for proteomics software. This software will enable the researchers to generate more results in comparatively less time.

In June 2017, Thermo Fisher Scientific Inc launched a new high-performing Orbitrap mass spectrometer. It is designed to produce superior quality results in the proteomics researches.

News From

P&S Market ResearchP&S Market Research
Category: Market Research Publishers and RetailersCompany profile: PS Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries. With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our pub ...

For more information:

Make an Inquiry about this report HERE!
  • www.psmarketresearch.com/market-analysis/proteomics-market
  • www.psmarketresearch.com/market-analysis…ket/report-sample
  • www.psmarketresearch.com/send-enquiry?en…proteomics-market
  • www.psmarketresearch.com